AC-262536 | 35mg/1,5mlAC-262536 | 35mg/1,5ml
$119.00
What is AC-262536?
AC-262536 is a selective androgen receptor modulator (SARM) that is of scientific interest for its ability to stimulate muscle growth and support physical strength without strongly affecting other androgen-sensitive organs. It is considered one of the mildest compounds in the SARM group, with a potential anabolic effect combined with low androgenic activity.
The molecule was created to offer an alternative to classical androgenic agents, focusing on maintaining muscle mass, especially in conditions where tissue loss is observed—such as aging, reduced activity, or caloric deficit. AC-262536 stands out with balanced action and a good profile for research protocols related to physical recovery and body composition.
Mechanism of action of AC-262536
AC-262536 acts through selective binding to androgen receptors, leading to activation of anabolic processes in muscle tissue without triggering receptors associated with undesirable effects on the prostate or other non-target areas.
The compound shows around 60% of the anabolic effect of testosterone at a significantly lower androgenic load. This makes it particularly suitable for laboratory studies seeking an impact on muscle function without hormonal fluctuations. At the same time, processes such as conversion to estrogens or water retention have not been observed, which supports a cleaner and more stable body composition.
Potential research-backed benefits of AC-262536
AC-262536 has been studied in various laboratory settings, where the following potential effects have been observed:
- Stimulation of muscle growth and strength, with limited systemic impact;
- Preservation of lean muscle mass during deficit or immobilization;
- Improvement in muscular endurance and tone under light to moderate loads;
- Small likelihood of estrogenic reactions, fluid retention, or hormonal side effects;
- Suitable for more delicate research models aiming for moderate but supportive anabolic action.
Its versatility makes it particularly suitable for studies focused on balancing muscle maintenance and safety.
Comparison of AC-262536 with other SARMs
AC-262536 is a less-known SARM that occupies a specific niche in research protocols aimed at achieving an anabolic effect with the lowest possible systemic risk. The molecule is structurally designed to provide moderate impact on muscle and bone tissue without strong androgenic stimulation. It is often compared with Ostarine (MK2866), ACP-105, and Ligandrol (LGD-4033), especially when more delicate approaches to recovery or maintenance are sought.
Compared with Ostarine, AC-262536 demonstrates a similar safety profile but usually with a weaker anabolic effect. While Ostarine is well established in research related to preserving muscle mass during deficit, AC-262536 is often used in recovery models seeking minimal systemic load—including longer-term schemes.
Compared with ACP-105, AC-262536 is even milder in action, which makes it suitable for supporting cycles, initial phases, or combined protocols where the goal is to minimize impact on the hormonal axis. ACP-105, in turn, provides more noticeable anabolic stimulation, but with a slightly higher androgenic load.
Relative to Ligandrol, which is many times more potent, AC-262536 is positioned as a gentle alternative, without substantial risks of suppression or hormonal imbalance. Instead of aggressive growth, AC-262536 provides mild, controlled stimulation that is particularly suitable when combined with other molecules such as Ibutamoren or Ecdysterone.
Dosage and application of AC-262536 in research protocols
Recommended research scheme: 5 units once daily, for 4–6 weeks, followed by 2–4 weeks off.
1 unit = 23.33mcg.
Total amount in pen: 150 units
Possible side effects of AC-262536
Although AC-262536 is considered one of the safer compounds among SARMs, observations include some side effects, especially with prolonged use or higher doses:
- Temporary suppression of testosterone production, depending on duration of intake;
- Individual sensitivity to androgenic stimulation, especially in more sensitive models;
- Limited long-term data.
Adhering to optimal dosing and controlling the duration of application play a key role in limiting the manifestation of side effects.
Disclaimer
For research use only. Not for human consumption.



